UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
Bar Harbor Bankshares
BHB
$666M
| $519K | ﹤0.01% |
16,983
+5,683
| +50% | +$188K |
|
5802
SmartRent
SMRT
$272M
| $517K | ﹤0.01% |
295,337
+148,180
| +101% | +$248K |
|
5803
Hooker Furnishings Corp
HOFT
$166M
| $511K | ﹤0.01% |
36,443
+30,742
| +539% | +$517K |
|
5804
Atlas Lithium Corp
ATLX
$91.7M
| $510K | ﹤0.01% |
80,640
+80,639
| +8,063,900% | +$614K |
|
5805
Superior Group of Companies
SGC
$225M
| $510K | ﹤0.01% |
30,871
+23,709
| +331% | +$380K |
|
5806
IDT Corp
IDT
$1.62B
| $510K | ﹤0.01% |
10,735
-367
| -3% | -$17.6K |
|
5807
SunCoke Energy
SXC
$797M
| $509K | ﹤0.01% |
47,555
-240,371
| -83% | -$2.58M |
|
5808
State Street SPDR S&P North American Natural Resources ETF
NANR
$777M
| $509K | ﹤0.01% |
9,955
-15,987
| -62% | -$894K |
|
5809
Bank7 Corp
BSVN
$481M
| $508K | ﹤0.01% |
10,896
+4,283
| +65% | +$189K |
|
|
INCE
5810
Franklin Income Equity Focus ETF
INCE
$138M
| $508K | ﹤0.01% |
9,165
+9,066
| +9,158% | +$525K |
|
5811
Oppenheimer Holdings
OPY
$1.2B
| $507K | ﹤0.01% |
7,916
+3,244
| +69% | +$188K |
|
5812
Lexicon Pharmaceuticals
LXRX
$1.1B
| $507K | ﹤0.01% |
686,117
+546,125
| +390% | +$658K |
|
|
TPZ
5813
Tortoise Electrification Infrastructure ETF
TPZ
$124M
| $507K | ﹤0.01% |
25,257
+6,230
| +33% | +$122K |
|
5814
iShares iBonds 2027 Term High Yield and Income ETF
IBHG
$507M
| $504K | ﹤0.01% |
22,665
+22,385
| +7,995% | +$501K |
|
5815
RPAR Risk Parity ETF
RPAR
$582M
| $503K | ﹤0.01% |
26,942
+3,638
| +16% | +$71.7K |
|
5816
CALL
CRISPR Therapeutics
CRSP
$5.17B
| $503K | ﹤0.01% |
12,784
-7,530
| -37% | -$356K |
|
|
DBVT
5817
DBV Technologies
DBVT
$847M
| $502K | ﹤0.01% |
+162,376
| New | +$553K |
|
5818
ProShares Bitcoin Strategy ETF
BITO
$1.45B
| $501K | ﹤0.01% |
+22,004
| New | +$488K |
|
5819
Cornerstone Strategic Value Fund
CLM
$2.25B
| $498K | ﹤0.01% |
58,877
+38,650
| +191% | +$319K |
|
|
TECX
5820
Tectonic Therapeutic
TECX
$606M
| $497K | ﹤0.01% |
10,774
+10,771
| +359,033% | +$456K |
|
5821
Compugen
CGEN
$228M
| $497K | ﹤0.01% |
324,581
+88,010
| +37% | +$143K |
|
5822
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $497K | ﹤0.01% |
21,066
+1,361
| +7% | +$31.5K |
|
5823
iShares iBonds 2028 Term High Yield and Income ETF
IBHH
$457M
| $496K | ﹤0.01% |
+21,235
| New | +$500K |
|
5824
Choiceone Financial
COFS
$510M
| $496K | ﹤0.01% |
13,908
+1,012
| +8% | +$34.7K |
|
|
AOMR
5825
Angel Oak Mortgage REIT
AOMR
$209M
| $494K | ﹤0.01% |
53,264
+27,715
| +108% | +$265K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.